Publisher
Springer Berlin Heidelberg
Reference77 articles.
1. Ad hoc group for the development of implementing guidelines for Directive 2001/20/EC (2008) Ethical considerations for clinical trials on medicinal products conducted with the paediatric population. https://ec.europa.eu/health//sites/health/files/files/eudralex/vol-10/ethical_considerations_en.pdf
2. Adashi EY, Walters LB, Menikoff JA (2018) The Belmont report at 40: reckoning with time. Am J Public Health 108(10):1345–1348. https://doi.org/10.2105/AJPH.2018.304580
3. Alarcon GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Alen J, Bastian HM, Vila LM, Reveille JD, Group LS (2007) Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 66(9):1168–1172. https://doi.org/10.1136/ard.2006.068676
4. Albrecht K (2017) Methodological approaches in the development of clinical guidelines. Z Rheumatol 76(2):104–110. https://doi.org/10.1007/s00393-016-0238-4
5. Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, Parsa MF, Zemel LS, Ronis T, Beukelman T, Cox E, Sen HN, Holland GN, Brunner HI, Lasky A, Rabinovich CE, Juvenile Idiopathic Arthritis D-S, Uveitis Subcommittee of the Childhood Arthritis R, Research A (2019) Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis. Arthritis Care Res 71(4):482–491. https://doi.org/10.1002/acr.23610